LALVÉE , Salomé

Last name: LALVÉE

First name: Salomé

August 22, 2017 (v1)

Journal article

Metadata-only

MiR-223-3p inhibits angiogenesis and promotes resistance to cetuximab in head and neck squamous cell carcinoma

Bozec, Alexandre Zangari, Joséphine Butori-Pepino, Mathilde

International audience

Uploaded on: December 4, 2022
June 2016 (v1)

Journal article

Metadata-only

High expression of TRF2, SOX10, and CD10 in circulating tumor microemboli detected in metastatic melanoma patients. A potential impact for the assessment of disease aggressiveness

Long, Elodie Ilie, Marius Bence, Coraline

International audience

Uploaded on: December 4, 2022
2019 (v1)

Journal article

Metadata-only

In-House Implementation of Tumor Mutational Burden Testing to Predict Durable Clinical Benefit in Non-Small Cell Lung Cancer and Melanoma Patients

Heeke, Simon Benzaquen, Jonathan Long-Mira, Elodie

Tumor mutational burden (TMB) has emerged as an important potential biomarker for prediction of response to immune-checkpoint inhibitors (ICIs), notably in non-small cell lung cancer (NSCLC). However, its in-house assessment in routine clinical practice is currently challenging and validation is urgently needed. We have analyzed sixty NSCLC and...

Uploaded on: December 4, 2022
July 2019 (v1)

Journal article

Metadata-only

Multicenter Evaluation of a Novel ROS1 Immunohistochemistry Assay (SP384) for Detection of ROS1 Rearrangements in a Large Cohort of Lung Adenocarcinoma Patients

Hofman, Véronique Rouquette, Isabelle Long-Mira, Elodie

INTRODUCTION:The detection of a ROS1 rearrangement in advanced and metastatic lung adenocarcinoma (LUAD) led to a targeted treatment with tyrosine kinase inhibitors with favorable progression-free survival and overall survival of the patients. Thus, it is mandatory to screen for the ROS1 rearrangement in all these patients. ROS1 rearrangements...

Uploaded on: December 4, 2022

LALVÉE , Salomé

Recent uploads